LAMOTRIZ 50 (Lamotrigine (50mg))
-71%

LAMOTRIZ 50 (Lamotrigine (50mg))

Original price was: ₹102.00.Current price is: ₹30.00.

Placeholder

Original price was: ₹102.00.Current price is: ₹30.00.

Add to cart
Buy Now
Category: Tag:

LAMOTRIZ 50 is an anti-epileptic drug indicated for managing two primary conditions: epilepsy and bipolar disorder. This medication functions by inhibiting the transmission of signals in the brain that lead to epileptic seizures, while also working to stabilize mood fluctuations associated with bipolar disorder. It can be administered as a standalone treatment or alongside other medications, depending on the physician’s direction. LAMOTRIZ 50 can be consumed with or without meals, and the specific dosage will be determined by your healthcare provider, who may gradually increase it until your medical condition is adequately controlled. Although the therapeutic effects of this medication may take several weeks to manifest fully, consistent adherence to the prescribed regimen is crucial for obtaining the best possible outcome. Patients are advised not to discontinue use abruptly, as doing so might result in an escalation of seizures or exacerbation of mood-related issues. It’s important to report any adverse reactions promptly, particularly skin rashes or peeling, as these may necessitate intervention. While many side effects tend to diminish over time, some may require medical attention, especially if they persist. Additionally, long-term usage carries potential risks such as the development of osteoporosis, which heightens the likelihood of bone fractures. Prior to initiation, it is essential to inform your physician about any pre-existing conditions, such as kidney or liver ailments, mental health concerns, and all other medications being taken, as interactions may occur. Regular monitoring through blood tests may be necessary to assess your response to treatment.

Reviews

There are no reviews yet.

Be the first to review “LAMOTRIZ 50 (Lamotrigine (50mg))”

Your email address will not be published. Required fields are marked *

Top